Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| AST SpaceMobile, Inc.CL A(ASTS) | 8,943,486 | 8,943,486 | 0 | $417.93M | $438.95M | 18.22% | +$21.02M |
| Planet Labs PBCCL A(PL) | 31,942,641 | 31,942,641 | 0 | $194.85M | $414.62M | 17.21% | +$219.77M |
| Arm Holdings PlcADS | 1,960,784 | 1,960,784 | 0 | $317.14M | $277.43M | 11.52% | -$39.71M |
| Metsera Inc | 4,961,744 | 3,783,528 | -1,178,216 | $141.16M | $197.99M | 8.22% | +$56.83M |
| Revolution Medicines, Inc.(RVMD) | 4,133,277 | 4,133,277 | 0 | $152.06M | $193.02M | 8.01% | +$40.96M |
| Freshworks Inc.CL A(FRSH) | 16,206,643 | 16,206,643 | 0 | $241.64M | $190.75M | 7.92% | -$50.89M |
| Tempus AI, Inc.CL A(TEM) | 1,551,102 | 1,551,102 | 0 | $98.56M | $125.19M | 5.20% | +$26.63M |
| GitLab Inc.CL A(GTLB) | 2,724,712 | 2,724,712 | 0 | $122.91M | $122.83M | 5.10% | -$81.7K |
| UiPath, Inc.CL A(PATH) | 7,034,337 | 7,034,337 | 0 | $90.04M | $94.12M | 3.91% | +$4.08M |
| Prime Medicine, Inc.(PRME) | 15,062,498 | 16,562,498 | +1,500,000 | $37.20M | $91.76M | 3.81% | +$54.55M |
| DexCom, Inc.(DXCM) | 1,036,937 | 1,036,937 | 0 | $90.51M | $69.78M | 2.90% | -$20.74M |
| Maze Therapeutics, Inc.(MAZE) | 2,412,471 | 2,412,471 | 0 | $29.60M | $62.56M | 2.60% | +$32.95M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 2,823,126 | +2,823,126 | $0 | $32.69M | 1.36% | +$32.69M |
| Figma, Inc.CL A(FIG) | 0 | 215,582 | +215,582 | $0 | $11.18M | 0.46% | +$11.18M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,464,015 | 1,464,015 | 0 | $6.60M | $10.85M | 0.45% | +$4.25M |
| Sana Biotechnology, Inc.(SANA) | 2,812,500 | 2,812,500 | 0 | $7.68M | $9.98M | 0.41% | +$2.31M |
| Oscar Health, Inc.CL A(OSCR) | 481,988 | 481,988 | 0 | $10.33M | $9.12M | 0.38% | -$1.21M |
| Dianthus Therapeutics, Inc.(DNTH) | 208,697 | 208,697 | 0 | $3.89M | $8.21M | 0.34% | +$4.32M |
| Relay Therapeutics, Inc.(RLAY) | 1,568,753 | 1,568,753 | 0 | $5.43M | $8.19M | 0.34% | +$2.76M |
| Beam Therapeutics Inc.(BEAM) | 321,604 | 321,604 | 0 | $5.47M | $7.81M | 0.32% | +$2.33M |
| Vera Therapeutics, Inc.CL A(VERA) | 241,264 | 241,264 | 0 | $5.68M | $7.01M | 0.29% | +$1.33M |
| Lyell Immunopharma, Inc.(LYEL) | 293,256 | 293,256 | 0 | $2.59M | $4.76M | 0.20% | +$2.17M |
| Foghorn Therapeutics Inc.(FHTX) | 500,901 | 500,901 | 0 | $2.35M | $2.45M | 0.10% | +$95.2K |
| GeneDx Holdings Corp.(WGS) | 22,711 | 22,711 | 0 | $2.10M | $2.45M | 0.10% | +$350.4K |
| Taysha Gene Therapies, Inc.(TSHA) | 640,882 | 640,882 | 0 | $1.48M | $2.10M | 0.09% | +$615.2K |
| TScan Therapeutics, Inc.(TCRX) | 1,077,080 | 1,077,080 | 0 | $1.56M | $1.96M | 0.08% | +$398.5K |
| Barinthus Biotherapeutics PlADS | 1,513,644 | 1,513,644 | 0 | $1.41M | $1.89M | 0.08% | +$484.4K |
| Spero Therapeutics, Inc.(SPRO) | 889,979 | 889,979 | 0 | $2.58M | $1.67M | 0.07% | -$907.8K |
| Tenaya Therapeutics, Inc.(TNYA) | 915,705 | 915,705 | 0 | $558.6K | $1.48M | 0.06% | +$924.9K |
| Hyperfine, Inc.CL A(HYPR) | 898,720 | 898,720 | 0 | $647.1K | $1.30M | 0.05% | +$656.1K |
| Endeavour Silver Corp.(EXK) | 23,205 | 23,205 | 0 | $1.23M | $1.27M | 0.05% | +$36.4K |
| Autolus Therapeutics plcADS(AUTL) | 698,262 | 698,262 | 0 | $1.59M | $1.14M | 0.05% | -$453.9K |
| Fractyl Health, Inc.(GUTS) | 662,584 | 662,584 | 0 | $1.07M | $1.05M | 0.04% | -$19.9K |
| Alector Inc | 175,866 | 175,866 | 0 | $246.2K | $520.6K | 0.02% | +$274.4K |
| IRulya Therapeutics Inc.(IRLA) | 189,122 | 189,122 | 0 | $312.1K | $308.3K | 0.01% | -$3.8K |
| Fulcrum Therapeutics, Inc.(FULC) | 14,262 | 14,262 | 0 | $98.1K | $131.2K | 0.01% | +$33.1K |
| Repligen Corporation(RGEN) | 383 | 383 | 0 | $47.6K | $51.2K | 0.00% | +$3.6K |
| Verve Therapeutics Inc | 12,168,489 | 0 | -12,168,489 | $136.65M | $0 | — | -$136.65M |